Holen Sie sich die Stockscreener-App
86.48
0.52%
0.45
Handel nachbörslich:
86.52
0.04
+0.05%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ALC?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$86.03
Offen:
$86.28
24-Stunden-Volumen:
3.30M
Relative Volume:
1.96
Marktkapitalisierung:
$42.55B
Einnahmen:
$9.93B
Nettoeinkommen (Verlust:
$1.12B
KGV:
38.27
EPS:
2.26
Netto-Cashflow:
$1.43B
1W Leistung:
+2.81%
1M Leistung:
-1.14%
6M Leistung:
-4.17%
1J Leistung:
-6.97%
1-Tages-Spanne:
$85.91
$87.31
1-Wochen-Bereich:
$84.59
$87.31
52-Wochen-Spanne:
$80.48
$101.10
Alcon Inc Stock (ALC) Company Profile
Vergleichen Sie ALC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
86.48 | 42.55B | 9.93B | 1.12B | 1.43B | 2.26 |
|
ISRG
Intuitive Surgical Inc
|
482.35 | 171.42B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
195.96 | 55.88B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
288.28 | 41.48B | 5.15B | 1.40B | 1.65B | 9.51 |
|
WST
West Pharmaceutical Services Inc
|
246.22 | 17.25B | 2.90B | 467.20M | 306.90M | 6.37 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-20 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-05-14 | Bestätigt | BTIG Research | Buy |
| 2025-03-28 | Bestätigt | Needham | Buy |
| 2025-03-25 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-01-24 | Bestätigt | Needham | Buy |
| 2025-01-10 | Hochstufung | Redburn Atlantic | Neutral → Buy |
| 2024-12-17 | Bestätigt | Needham | Buy |
| 2024-11-12 | Bestätigt | Needham | Buy |
| 2024-10-10 | Hochstufung | Redburn Atlantic | Sell → Neutral |
| 2024-09-10 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-07-15 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-05-15 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2024-04-10 | Eingeleitet | Goldman | Buy |
| 2024-03-14 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2024-02-06 | Fortgesetzt | KeyBanc Capital Markets | Overweight |
| 2024-01-23 | Eingeleitet | Bernstein | Outperform |
| 2023-12-18 | Herabstufung | Redburn Atlantic | Neutral → Sell |
| 2023-12-12 | Eingeleitet | Stifel | Buy |
| 2023-12-04 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2023-08-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-05-30 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-05-10 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2023-03-01 | Hochstufung | Societe Generale | Sell → Hold |
| 2022-12-22 | Eingeleitet | Mizuho | Buy |
| 2022-11-17 | Herabstufung | Societe Generale | Hold → Sell |
| 2022-08-11 | Herabstufung | Societe Generale | Buy → Hold |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-05-12 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2022-04-08 | Eingeleitet | Needham | Buy |
| 2022-03-11 | Eingeleitet | BofA Securities | Buy |
| 2022-01-18 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-10-01 | Eingeleitet | Oppenheimer | Perform |
| 2021-07-14 | Eingeleitet | Deutsche Bank | Buy |
| 2021-05-06 | Hochstufung | Citigroup | Sell → Neutral |
| 2021-03-22 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-11-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-07-06 | Herabstufung | Citigroup | Neutral → Sell |
| 2020-07-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-06-16 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-04-08 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | Hochstufung | Argus | Hold → Buy |
| 2020-03-24 | Hochstufung | Societe Generale | Sell → Hold |
| 2020-03-13 | Hochstufung | UBS | Neutral → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Neutral |
| 2020-02-26 | Hochstufung | Berenberg | Hold → Buy |
| 2020-01-08 | Eingeleitet | Argus | Hold |
| 2019-10-29 | Eingeleitet | Stephens | Equal-Weight |
| 2019-08-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-06-24 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2019-06-14 | Eingeleitet | BTIG Research | Neutral |
| 2019-05-10 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-05-02 | Eingeleitet | Credit Suisse | Outperform |
Alle ansehen
Alcon Inc Aktie (ALC) Neueste Nachrichten
Alcon Poised to Deliver Q2 Sales Beat, Full-Year Guidance Raise, Needham Says - MarketScreener
Alcon announces purchase of STARR Surgical for $1.5 billion - MSN
Takeover Agreement with Alcon Sparks Sharp Weekly Gains for STAAR Surgical - uk.finance.yahoo.com
Key deals this week: Walt Disney, Harrison Global, Alcon, Steelcase, Joby Aviation and more - Seeking Alpha
STAAR Surgical's largest holder demands books, records on Alcon deal - MSN
Lensar Inc. Q2 Earnings: Revenue Up 10%, Merger with Alcon on Track for End-2025 Close - AInvest
Broadwood Capital Demands Books and Records on STAAR Surgical-Alcon Deal. - AInvest
STAAR Surgical's largest holder demands books, records on Alcon deal (update) (STAA:NASDAQ) - Seeking Alpha
Alcon (ALC) Stock Price, News & Analysis - MarketBeat
Kepler Capital Maintains Buy Rating on Alcon with CHF86.00 Price Target - AInvest
RxSight (RXST) Q2 Loss Beats Estimates - The Motley Fool
Assessing the STAAR Surgical-Alcon Deal: Is the $28-Per-Share Offer a Bargain or a Missed Opportunity? - AInvest
Saudi Arabia OTC Artificial Tears Market Forecast and Company Analysis Report 2025-2033 Featuring AbbVie, Akorn, Alcon, Bausch Health, J&J, Nicox, Novartis, Santen Pharmaceutical, Sun Pharmaceutical - Yahoo Finance
Staar Surgical 2025 Q2 Earnings Sharp Loss Amid Acquisition by Alcon - AInvest
Stifel downgrades STAAR Surgical stock to Hold following Alcon acquisition By Investing.com - Investing.com Australia
Stifel downgrades STAAR Surgical stock to Hold following Alcon acquisition - Investing.com
Alcon to Buy Staar for $1.5 Billion in Vision Surgery Expansion - MSN
STAAR Surgical Sale to Alcon Raises Concerns Among Investors - AInvest
Market Reverses Gains, Focus on Exxon, Intel, and Alcon - AInvest
Alcon to Acquire STAAR Surgical in $1.5 Billion Deal - The Globe and Mail
Alcon agrees to acquire STAAR Surgical - Ophthalmology Times
Bright move: Alcon offers $1.5B for Staar Surgical - BioWorld MedTech
Alcon to acquire STAAR Surgical - Eyes On Eyecare
STAAR Surgical stock rating downgraded to Neutral by Sidoti on Alcon deal - Investing.com Nigeria
Alcon to Acquire Staar Surgical for $1.5B - Orange County Business Journal
Alcon agrees to acquire STAAR Surgical for $1.5 billion equity value - MLex
Alcon to acquire STAAR Surgical for about $1.5B - MedTech Dive
STAAR Surgical stock soars after Alcon announces $1.5B acquisition By Investing.com - Investing.com Canada
Why Is STAAR Surgical Stock Skyrocketing Tuesday?Alcon (NYSE:ALC), Staar Surgical (NASDAQ:STAA) - Benzinga
Alcon to Buy STAAR Surgical for $1.5 Billion - Medical Product Outsourcing
Staar Surgical Stock (STAA) Soars on $1.5B Alcon Deal - TipRanks
Staar Surgical Merges with Alcon in $1.5B Deal - TipRanks
First Look: PG&E Surges, Intel Downgraded, and Alcon Acquires ST - GuruFocus
Alcon to Acquire STAAR Surgical for $1.5 Billion - TipRanks
Alcon strikes $1.5bn deal to acquire ailing rival STAAR Surgical - Yahoo Finance
Alcon Buys STAAR Surgical To Expand Eye Care Portfolio - Finimize
Why Did STAAR Surgical Soar 46.02%? Alcon Acquisition - AInvest
Alcon to Buy Nasdaq-listed Staar Surgical for $1.5 Billion - MarketScreener
Alcon to buy STAAR Surgical for $1.5 billion - breakingthenews.net
Alcon to buy eye health firm STAAR Surgical for $1.5 bln - Investing.com Canada
Alcon Agrees to Acquire STAAR Surgical - Business Wire
Alcon Inc. Sees Relief Buying After Extended DropBuy Alerts With Low Risk Confirmation Noted - metal.it
How does Alcon Inc. generate profit in a changing economyConsistent high-performance stocks - Jammu Links News
What catalysts could drive Alcon Inc. stock higher in 2025Get daily expert analysis on top stocks - Jammu Links News
What markets is Alcon Inc. expanding into Is TECX stock a good long term investment optionGrow your portfolio with growth-oriented stocks - Jammu Links News
What analysts say about Alcon Inc. stockRemarkable growth - Jammu Links News
What institutional investors are buying Alcon Inc. stockAccelerated investment success - Jammu Links News
Is it the right time to buy Alcon Inc. stockSkyrocketing profit margins - Jammu Links News
What drives Alcon Inc. stock priceCapitalize on market momentum for maximum gains - Jammu Links News
What is the dividend policy of Alcon Inc. stockBuild a portfolio that outperforms the market - Jammu Links News
What are the latest earnings results for Alcon Inc.Triple-digit wealth increases - Jammu Links News
Finanzdaten der Alcon Inc-Aktie (ALC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):